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Abstract
Organic anion transporting polypeptides (OATPs) have been extensively recognized as key determinants of absorption,
distribution, metabolism and excretion (ADME) of various drugs, xenobiotics and toxins. Putative N-glycosylation sites
located in the extracellular loops 2 and 5 is considered a common feature of all OATPs and some members have been
demonstrated to be glycosylated proteins. However, experimental evidence is still lacking on how such a post-translational
modification affect the transport activity of OATPs and which of the putative glycosylation sites are utilized in these
transporter proteins. In the present study, we substituted asparagine residues that are possibly involved in N-glycosylation
with glutamine residues and identified three glycosylation sites (Asn134, Asn503 and Asn516) within the structure of
OATP1B1, an OATP member that is mainly expressed in the human liver. Our results showed that Asn134 and Asn516 are
used for glycosylation under normal conditions; however, when Asn134 was mutagenized, an additional asparagine at
position 503 is involved in the glycosylation process. Simultaneously replacement of all three asparagines with glutamines
led to significantly reduced protein level as well as loss of transport activity. Further studies revealed that glycosylation
affected stability of the transporter protein and the unglycosylated mutant was retained within endoplasmic reticulum.
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Introduction
The organic anion-transporting polypeptides (OATPs, gene
symbol SLCO) are a family of transporters that mediate sodium-
independent transport of a wide spectrum of structurally
independent compounds [1]. Substrates of OATPs are mainly
amphipathic organic molecules including bile salts, hormones and
their conjugates, toxins and different drugs. In recent years,
OATPs have been extensively recognized as key determinants of
absorption, distribution, metabolism and excretion (ADME) of
various drugs, xenobiotics and toxins because of their broad
substrate specificity, wide tissue distribution and the involvement
of drug-drug interaction [2,3]. So far there are 12 members of the
human OATP family: OATP1A2, 1B1, 1B3, 1B7, 1C1, 2A1, 2B1,
3A1, 4A1, 4C1, 5A1 and 6A1 [4–7]. Some OATPs are expressed
ubiquitously; while others, such as OATP1B1 and OATP1B3, are
predominantly found in certain organs or tissues. OATP1B1 is
mainly located at the basolateral membrane of human hepatocytes
and play an essential role in drug clearance from the body [8]. In
recent years, more and more drugs are identified as substrates of
this OATP family member [9].
As the most common and diverse form of post-translational
modification for newly synthesized proteins, glycosylation is widely
found in integral membrane proteins of higher organism and also
common in secretory proteins [10]. Many transporters are found
to possess glycosylation sites in their amino acid sequences. For
instance, one common feature for the organic anion transporter
(OAT) family members is the presence of consensus sites for N-
linked glycosylation within the extracellular loop between trans-
membrane domain (TM) 1 and 2. Disruption of all four putative
glycosylation sites in both mOAT1 and hOAT1 impaired the
trafficking of the transporter to the cell surface as well as the
transport of p-amminohippuric acid [11]. Study on glycosylation
of organic cation transporter (OCT) showed that the oligosaccha-
ride moiety(s) may be located close to the binding site for organic
cations and that glycosylation of OCT is critical for the proper
conformation of the binding pocket [12]. Putative N-glycosylation
sites (NX(S/T), where X is any amino acid except proline) located
in the extracellular loops 2 and 5 is considered a common feature
of all OATP proteins [6]. Wang et al. showed that rat oatp1a1 is
glycosylated at asparagines 124, 135, and 492 in the second and
fifth extracellular loops, while the potential glycosylation site at
asparagine 62 is not utilized [13]. Although it has been
demonstrated that some OATPs are glycosylated proteins [14–
16], experimental evidence is still lacking on how such a post-
translational modification affects the function of OATPs and
which of the putative glycosylation sites are utilized in these
transporter proteins.
In the present study, we disrupted the putative N-glycosylation
sites (Asn134, 432, 503, 516 and 617) in OATP1B1 by substituting
asparagine (N) with glutamine (Q) and assessed these mutant
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transporters in HEK293 cells. Our results revealed that asparagine
134, 516 and 503 are glycosylated in OATP1B1. When all three
sites were simultaneously substituted with glutamine, the trans-
porter protein became unglycosylated and presented a dramati-
cally decreased level of protein expression as well as loss of
transport function.
Materials and Methods
Materials
[3H]Estrone-3-sulfate (E-3-S) was purchased from PerkinElmer
Life Sciences (Waltham, MA). Sulfosuccinimidyl 2-(biotinamido)-
ethyl-1, 3-dithiopropionate (NHS-SS-biotin) and streptavidin-
agarose beads were from Thermo Scientific (Rockford, IL). All
other reagents were purchased from Sigma except where
otherwise stated.
Site-directed Mutagenesis
Mutant transporters were generated using QuikChange Light-
ning Site-Directed Mutagenesis Kit from Agilent (Santa Clara,
CA). The pReceriver M07 vector containing the SLCO1B1 cDNA
and 3-HA tags at the C-terminus was obtained from Genecopoeia
(Rockville, MD) and used as the template for the mutagenesis. All
mutant sequences were confirmed by the dideoxy chain termina-
tion method.
Cell Culture and Transfection of Plasmid Constructs into
Cells
HEK293 cells (ATCC, Manassas, VA) were grown at 37uC and
5% CO2 in Dulbecco’s modified Eagle’s medium (Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine serum
(Invitrogen). Confluent cells in 48-well or 6-well plates were
transfected with DNA plasmid using LipofectAMINE 2000
reagent (Invitrogen) following manufacturer’s instruction. Trans-
fected cells were incubated for 48 h at 37uC and then used for
transport assay and cell surface biotinylation.
Cell Surface Biotinylation and Western Blot
Cell surface expression level of OATP1B1 and their mutants
were examined using the membrane-impermeable biotinylation
reagent NHS-SS-biotin with the method described previously
Figure 1. OATP1B1 is glycosylated in HEK293 cells. A. The effect of tunicamycin on protein size of OATP1B1. B. Transport of E-3-S (0.1 mM) in
OATP1B1-expressed HEK293 cells with or without tunicamycin treatment. C. Plasma membrane proteins from cells expressing OATP1B1 treated with
N-glycosidase F. Cells expressing OATP1B1 were treated with 0.5 mg/ml of tunicamycin for 42 h before analysis. For protein expression, cells were
lysed with RIPA buffer, separated by SDS-PAGE, followed by Western blotting with anti-HA antibody. Fifty micrograms of protein was loaded for each
lane. Transport function of tunicamycin treated cells was expressed as a percentage of the uptake measured in the untreated control. The results
represent data from three experiments, with triplicate measurements for each sample. The results shown are means 6 S.E. (n = 3). For glycosidase
treatment, cell surface proteins were biotinylated and precipitated with streptavidin beads. Proteins were then denatured with 0.5%SDS and 1% b-
mercaptoethanol at 75uC for 15 min. The denatured proteins were incubated with or without N-glycosidase F overnight at 37uC before subjected to
SDS-PAGE.
doi:10.1371/journal.pone.0052563.g001
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[17]. Briefly, forty-eight hours after transfection, HEK293 cells in
6-well plates were labeled with NHS-SS-biotin (0.5 mg/ml in
phosphate-buffered saline (PBS)). The cells were then dissolved on
ice for 1 h in 400 ml of RIPA buffer (50 mM Tris, 150 mM NaCl,
Figure 2. Secondary structure model of OATP1B1. Putative glycosylation sites were identified with NetNGlyc 1.0 Server and compared with
membrane protein topology prediction analysis TopPred (Kyte-Doolittle hydrophobicity scale), only asparagines located extracellularly were
considered as candidates for glycosylation sites. Putative sites were marked as black diamonds and each position was indicated with arrows.
doi:10.1371/journal.pone.0052563.g002
Figure 3. Effect of single disruption of putative glycosylation sites. A. Western blot analysis of single mutants. Plasma membrane proteins
were isolated from cells expressing wild-type OATP1B1 and mutants through biotinylation. Same blot was probed with integrin antibody as surface
protein loading control. B. Transport of E-3-S (0.1 mM) in OATP1B1 and five single mutants. Transport function of mutants was expressed as a
percentage of the uptake measured in wild-type. The results represent data from three experiments, with triplicate measurements for each mutant.
The results shown are means 6 S.E. (n = 3). C. Plasma membrane proteins of wild-type OATP1B1 and N134Q treated with N-glycosidase F.
Glycosidase treatment was performed as described above.
doi:10.1371/journal.pone.0052563.g003
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0.1% SDS, 1% NP-40, protease inhibitors phenylmethylsulfonyl
fluoride, 200 mg/ml, leupeptin, 3 mg/ml, pH 7.4). The cell debris
was removed by centrifugation and streptavidin-agarose beads
were added to bind the biotin-labeled cell membrane proteins.
Protein was released and denatured in 46Laemmli buffer and
loaded onto a 7.5% SDS-polyacrylamide electrophoresis gel and
then transferred electrophoretically to a polyvinylidene difluoride
membrane (Millipore, Billerica, MA). OATP1B1 was detected
with an anti-HA antibody (Cell Signaling Technology, Danvers,
MA).
Deglycosylation of Plasma Membrane Proteins with N-
glycosidase F
Cell surface proteins were isolated with cell surface biotinylation
method described above. Proteins were then denatured in
0.5%SDS and 1% b-mercaptoethanol at 75uC for 15 min. The
denatured proteins were cooled to room temperature, then
incubated with 50 mM sodium hydrogen phosphate (pH7.5), 1%
Nonidet P-40 and 5 ml of N-glycosidase F (100 units/ml, Roche,
Indianapolis, IN) overnight at 37uC.
Uptake Assay
Cells in 48-well plates were used for transport measurement as
described before [17] with minor modifications. Briefly, cells were
incubated with uptake solution (125 mM NaCl, 4.8 mM KCl,
5.6 mM D-glucose, 1.2 mM KH2PO4, 25 mM HEPES, 1.2 mM
CaCl2, and 1.2 mM MgCl2, pH7.4 and [
3H]E-3-S) for 2 min at
37uC and the uptake process was stopped by adding ice-cold PBS
solution into each well. Cells were then solubilized in 0.2 N NaOH
and the radioactivity of cell lysate was measured with a liquid
scintillation counter Triathler-Hidex (Hidex, Finland). Uptake
count was standardized by the amount of protein in each well.
Immunofluorescence Analysis of Transfected Cells
Forty-eight hours after transfection, transfected HEK293 cells
were washed three times with PBS and fixed with 4% parafor-
maldehyde for 20 min at room temperature. The fixed cells were
permeabilized with 0.1% Triton X-100 for 10 min, washed with
PBS and incubated with PBS containing 5% goat serum for 1 h at
room temperature. Primary antibodies (dilution 1:100) in the same
medium was then added and incubated overnight at 4uC. The
cells were washed, and bound primary antibodies were detected by
Figure 4. Effect of multiple disruption of OATP1B1 glycosylation sites. A. Western blot analysis for plasma membrane protein expression of
double mutants. B. Transport of E-3-S (0.1 mM) in OATP1B1 and double mutants. C. Western blot analysis for plasma membrane protein expression of
triple mutants. D. Plasma membrane proteins of wild-type OATP1B1 and N134/503/516Q treated with N-glycosidase F. E. Total protein expression of
OATP1B1 and triple mutants. Same blot was probed with actin antibody as loading control. F. Western blot analysis of wild-type OATP1B1 and triple
mutant N134/503/516Q treated with proteasome inhibitor MG132. Cells were treated with 10 mM MG132 for 6 h before being lysed with RIPA buffer
and subjected to Western blotting. Fifty micrograms of protein was loaded for each lane.
doi:10.1371/journal.pone.0052563.g004
N-glycosylation Affects Stability of OATP1B1
PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e52563
reaction with Alexa Fluor 488 goat anti-mouse or Alexa Fluor 555
goat anti-rabbit IgG antibody diluted 1:1000 (Cell Signaling
Technology) for 1 h. Cells were thoroughly washed and the cover
glasses were mounted in Fluoromount mounting medium.
Samples were examined using a Zeiss LSM 710 confocal
microscope (Carl Zeiss, Oberkochen, Germany).
Figure 5. Functional analysis of triple glycosylation site mutants. Cells were incubated with 0.1 mM E-3-S for 2 min at 37uC. Transport
function of mutants was expressed as a percentage of the uptake measured in wild-type OATP1B1. The results represent data from three
experiments, with triplicate measurements for each mutant. The results shown are means 6 S.E. (n = 3). Asterisks indicate values significantly
different (p,0.05) from that of wild-type OATP1B1.
doi:10.1371/journal.pone.0052563.g005
Figure 6. Immunofluorescence study of triple mutant N134/503/516Q. Cells expressing OATP1B1 wild-type and N134/503/516Q were
stained with anti-HA antibody (1:100) and anti-calnexin antibody (1:100) and reacted with Alexa Fluor 488 goat anti-mouse IgG or Alexa Fluor 555
goat anti-rabbit IgG antibody. Specific immunostaining shown as green (OATP1B1) or red (calnexin) fluorescence.
doi:10.1371/journal.pone.0052563.g006
N-glycosylation Affects Stability of OATP1B1
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Statistical Analysis
Data statistical analysis was carried out using Student’s t-test.
Differences between means are regarded as significant if p,0.05.
Results
N-Glycosylation of OATP1B1
It has been shown that mature OATPs are glycosylated proteins
in vivo [14–16]. To investigate whether OATP1B1 is glycosylated
and whether such a post-translational modification affects
transport activity in HEK293 cells, we first treated cells expressing
OATP1B1 with tunicamycin, a general inhibitor of glycosylation.
Treatment of 0.5 mg/ml of tunicamycin for 42 h resulted in a
reduced molecular mass in Western blot analysis. The molecular
size of the signal was ,72 kDa and consistent with the predicted
size (unglycosylated form) for OATP1B1 (Fig. 1A). Moreover, the
pretreatment of tunicamycin significantly suppressed transport
activity as well as protein level of OATP1B1 (Fig.1A&B). We also
treated plasma membrane proteins isolated from cells expressing
OATP1B1 with N-glycosidase F, an enzyme that removes the N-
linked carbohydrate groups from glycoproteins. As indicated in
Figure 1C, the molecular mass reduced from 95 kDa to a smaller
size of 72 kDa. These results suggested that OATP1B1 is
glycosylated in HEK293 cells and that glycosylation affects its
transport function.
Effect of Disruption of Individual Putative Glycosylation
Sites
OATP1B1 has a proposed topology of 12 transmembrane
domains with both amino- and carboxyl- termini located
intracellularly. According to computer analysis with Kyte-
Doolittle hydrophobicity scale, five consensus sites (NX(S/T)) for
N-glycosylation, located in the second, fifth and sixth extracellular
loops of OATP1B1, were identified (Fig. 2). To assess which of
these positions are utilized for glycosylation, we disrupted the
glycosylation sites individually by site-directed mutagenesis,
substituting asparagine (N) with glutamine (Q). As shown in
Figure 3, the replacement of N432, N503 and N617 with
glutamine did not seem to affect the size of the transporter
protein. On the other hand, mutant N134Q presented a much
reduced molecular weight compared with that of the wild-type
OATP1B1. Mutation on position 516 also led to decrease in
molecular weight, though to a much lesser extend than N134Q.
However, all five mutants retained cell surface protein expression
level as well as transport activity (Fig.3A&B). Since the size change
in N516Q was subtle, we treated N134Q mutant with N-
glycosidase F to make sure whether position 134 is the only
glycosylation site of OATP1B1 and responsible for the increased
molecular weight of the mature transporter protein. Such a
treatment resulted in a more reduced molecular mass (Fig.3C)
compared with the untreated sample, implicating that in addition
to Asn134, there are other positions involved in glycosylation.
Effect of Multiple Disruptions of Putative Glycosylation
Sites
To further investigate the participation of other putative sites in
glycosylation, we then generated double mutants using N134Q as
the template. Again, cell surface expression level and transport
activity of all four double mutants were comparable with that of
the wild-type OATP1B1, though molecular weight of double
mutant N134/503Q and N134/516Q both decreased marginally
(Fig. 4A&B) compared to that of N134Q. Since the single
substitution of asparagine with glutamine at position 134 and 516
both led to a reduced molecular mass, suggesting the two positions
are utilized under normal conditions, triple mutants using N134/
516Q as template were generated. As shown in Figure 4C,
simultaneously substituting Asn134, 503 and 516 with glutamine
caused significantly decreased protein level on plasma mem-
brane(,10%). The triple mutant had a smaller molecular weight
that was similar to the 72 kDa unglycosylated form of OATP1B1.
To confirm that there are no additional sites for N-glycosylation in
OATP1B1, we treated cells expressing the triple mutant with N-
glycosidase F. As shown in Fig. 4D, molecular mass of N134/503/
516Q was the same with or without glycosidase treatment,
indicating these three locations are the only glycosylation sites
within the structure of OATP1B1. To investigate whether the level
of N134/503/516Q on the plasma membrane was reduced due to
a decreased amount of total protein present in the cell or the
failure of transporter protein targeting to the cell surface, we
analyzed total protein level of the triple mutant. Our results
showed that total protein level of N134/503/516Q was also
greatly reduced, correlated well with its cell surface expression,
suggesting the absence of glycosylation in OATP1B1 affected total
protein level (Fig. 4E). Moreover, treatment with MG132, a
specific and potent proteasome inhibitor, resulted in accumulation
of the 72 kDa unglycosylated transporter protein in total cell
extracts of both the wild type and N134/503/516Q mutant
(Fig. 4F). In addition, the impact of simultaneously mutagenized
these three putative glycosylatoin sites on the function of
OATP1B1 was examined. Consistent with our Western blot
analysis, the triple mutant showed much reduced transport activity
(Fig. 5).
N134/503/516Q was Retained within the Endoplasmic
Reticulum
Since N134/503/516Q had a much reduced protein level and
responded to proteasome inhibitor, we next wanted to identify the
subcellular location of the mutant so as to have a better
understanding of the degradation process. As shown in Figure 6,
immunofluorescence signal of N134/503/516Q was colocalized
with the endoplasmic reticulum (ER)-specific protein calnexin,
suggesting the triple mutant was trapped in the protein processing
organelle. On the other hand, the wild-type transporter protein
was located on the cell membrane as well as in the ER.
Discussion
Glycosylation is a major post-translational modification in
membrane proteins. Studies had shown that such a process can
impair membrane targeting as well as protein stability [11,13,18].
Moreover, naturally occurring glycosylation-defective mutant had
been observed in organic anion transporting polypeptide family
member OATP1A2 [15], suggesting this post-translational mod-
ification may be essential for proper function of various transporter
proteins.
In the present study, we investigated the possible sites involved
in glycosylation of OATP1B1 and how such a modification affects
the function of the transporter protein. According to the computer
model based on Kyte-Doolittle hydrophobicity scale, OATP1B1
has 12 putative transmembrane domains. There are five consensus
sites (NX(S/T)) for N-glycosylation located in the second, fifth and
sixth extracellular loops of OATP1B1 and possibly involved in its
glycosylation process. Site-directed mutagenesis revealed that
there was a size reduction occurred in N134Q and N516Q
(Fig. 3A). However, such a replacement of individual asparagine
residues affected neither cell surface protein level nor transport
activity of the mutants. Interestingly, for double mutants that used
N-glycosylation Affects Stability of OATP1B1
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N134Q as the template, N134/503Q showed a similar protein
molecular size shift as N134/516Q did, suggesting that an
additional site at Asn503 is utilized when Asn134 was mutagen-
ized. However, it is also possible that Asn503 is used for
glycosylation under normal conditions though no size change
was observed. The single mutation at this position might not cause
a size reduction as obvious as N134Q and N516Q. Again,
simultaneous mutation of any two of these three asparagine
residues only affected size of the transporter protein. Cell surface
protein level and transport function, on the other hand, were
unchanged. Only when all three sites of Asn134, 503 and 516 were
eliminated would it lead to dramatically reduced protein level on
the plasma membrane as well as its uptake function. Further
analysis demonstrated that the decreased level of transporter
protein on cell surface was due to the reduced total protein
expression, implicating glycosylation may play a role in maintain-
ing protein stability. Indeed, treatment with MG132, a potent
proteasome inhibitor, resulted in partial recovery of the 72 kDa
unglycosylated form of the transporter protein (Fig. 4F). That
stability of OATP1B1 may be affected by glycosylation was also
evidenced in tunicamycin treatment. HEK293 cells expressing
wild-type OATP1B1 treated with tunicamycin showed not only
lower molecular weight but also much reduced protein level
compared with the untreated control (Fig. 1A). Therefore, the
much decreased transport function of OATP1B1 triple mutant
was likely due to the significantly reduced level of protein
expression. A previous study on rat oatp1a1 demonstrated that
three (Asn124, 135, and 492) out of the four putative glycosylation
sites in oatp1a1 are utilized and that the fully unglycosylated
transporter protein only had limited transport function due to its
reduced cell surface expression. However, unlike what was
observed in our current study, total protein level of the
unglycosylated oatp1a1 was almost unchanged [13], suggesting
glycosylation plays different roles in different transporter proteins.
It is interesting to note that though the glycosylation sites identified
in oatp1a1 is not a one-to-one pair-up with the three asparagine
residues in OATP1B1, they both are located on extracellular loop
2 or 5 of the transporter protein structure. Putative glycosylation
sites in other positions such as Asn617 localized in extracellular
loop 6 seems not to be involved in the glycosylation process.
Polymorphism analysis of SLCO1A2 gene that encodes another
OATP member OATP1A2 revealed a genetic variation, A404T,
which leads to substitution of an asparagine residue at position 135
with an isoleucine. This variant showed an apparent shift in the
molecular size of the transporter as well as a much reduced protein
level, implicating that the mutation at a single glycosylation site of
OATP1A2 could affect stability of the protein [15]. Although
Asn135 in OATP1A2 corresponds to Asn134 in OATP1B1, our
results demonstrated that a single replacement of asparagine
residue with glutamine had no effect on either protein level or
transport activity of OATP1B1. Whether this is due to the
difference between OATP family members, or the substitution of
asparagine with isoleucine resulted in a more dramatic effect on
the protein than a structurally similar glutamine remains to be
elucidated.
It has been shown that oligosaccharide chains confer stability on
many extracellular glycoproteins. Some proteins require N-linked
oligosaccharides in order to fold properly in the ER [19].
Moreover, glycosylation is often cited as having a stabilizing effect
upon proteins with respect to proteolysis [20]. The initial addition
of oligosaccharide occurs in the ER. Unglycosylate proteins are
often considered as misfolded, remained in the ER by default and
eventually subjected to degradation [21]. Our immunocytochem-
ical analysis demonstrated that the unglycosylated mutant N134/
503/516Q was retained within the ER, implicating that for
OATP1B1, glycosylation may be required for its proper folding
that ensures its exit from the ER. The fully unglysylated form
(N134/503/516Q) could not pass the quality control machinery,
and thus sorted as misfolded proteins and targeted for degradation.
In summary, our study identified three glycosylation sites, i.e.
Asn134, Asn503 and Asn516, which located at extracellular loop 2
and 5 of OATP1B1; while Asn432 and Asn617, the other two
putative sites, do not seem to participate in glycosylation process of
the transporter protein. Disruption of individual glycosylation site
did not affect proper processing and transport function of
OATP1B1. On the other hand, simultaneously mutation of all
three glycosylation sites resulted in a significantly reduced total
protein level, which led to loss of uptake function. The
unglycosylated form of the transporter was retained within the
ER and may be subjected to accelerated degradation.
Author Contributions
Conceived and designed the experiments: MH. Performed the experi-
ments: JY WH JH KZ. Analyzed the data: HH MH. Contributed
reagents/materials/analysis tools: HH MH. Wrote the paper: MH.
References
1. Hagenbuch B,Gui C (2008) Xenobiotic transporters of the human organic anion
transporting polypeptides (OATP) family. Xenobiotica 38: 778–801.
2. Shitara Y, Sato H, Sugiyama Y (2005) Evaluation of drug-drug interaction in the
hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol 45:
689–723.
3. Poirier A, Funk C, Lave´ T, Noe´ J (2007) New strategies to address drug-drug
interactions involving OATPs. Curr Opin Drug Discov Dev 10: 74–83.
4. Hagenbuch B, Meier PJ (2003) The superfamily of organic anion transporting
polypeptides. Biochim Biophys Acta 1609:1–18.
5. Mikkaichi T, Suzuki T, Tanemoto M, Ito S, Abe T (2004) The organic anion
transporter (OATP) family. Drug Metab Pharmacokinet 19: 171–179.
6. Ko¨nig J, Seithel A, Gradhand U, Fromm MF (2006) Pharmacogenomics of
human OATP transporters. Pharmacogenomics of human OATP transporters.
Naunyn Schmiedebergs Arch Pharmacol 372: 432–443.
7. Nakanishi T, Tamai I (2012) Genetic polymorphisms of OATP transporters and
their impact on intestinal absorption and hepatic disposition of drugs. Drug
Metab Pharmacokinet 27: 106–121.
8. Kalliokoski A, Niemi M (2009) Impact of OATP transporters on pharmacoki-
netics. Br J Pharmacol. 158: 693–705.
9. van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ et al.
(2003) Drug uptake systems in liver and kidney. Curr Drug Metab 4: 185–211.
10. Sharon N,Lis H (1993) Protein glycosylation: Structural and functional aspects.
FEBS 218: 1–27.
11. Tanaka K, Xu W, Zhou F, You G (2004) Role of glycosylation in the organic
anion transporter OAT1. J Biol Chem 279: 14961–14966.
12. Ott RJ, Hui AC, Giacomini KM (1992) Inhibition of N-linked glycosylation
affects organic cation transport across the brush border membrane of opossum
kidney (OK) cells. J Biol Chem 267:133–139.
13. Wang P, Hata S, Xiao Y, Murray JW, Wolkoff AW (2008) Topological
assessment of oatp1a1: a 12-transmembrane domain integral membrane protein
with three N-linked carbohydrate chains. Am J Physiol Gastrointest Liver
Physiol 294: G1052-G1059.
14. Ko¨nig J, Cui Y, Nies AT, Keppler D (2000) A novel human organic anion
transporting polypeptide localized to the basolateral hepatocyte membrane.
Am J Physiol Gastrointest Liver Physiol 278: G156-G164.
15. Lee W, Glaeser H, Smith LH, Roberts RL, Moeckel GW et al. (2005)
Polymorphisms in human organic anion-transporting polypeptide 1A2
(OATP1A2): implications for altered drug disposition and central nervous
system drug entry. J Biol Chem 280: 9610–9617.
16. Ho RH, Tirona RG, Leake BF, Glaeser H, Lee W et al. (2006) Drug and bile
acid transporters in rosuvastatin hepatic uptake: function, expression, and
pharmacogenetics. Gastroenterology 130: 1793–1806.
17. Li N, Hong W, Huang H, Lu H, Lin G et al. (2012) Identification of Amino
Acids Essential for Estrone-3-Sulfate Transport within Transmembrane Domain
2 of Organic Anion Transporting Polypeptide 1B1. PLoS One. 7: e36647.
18. Mochizuki K, Kagawa T, Numari A, Harris MJ, Itoh J et al. (2007) Two N-
linked glycans are required to maintain the transport activity of the bile salt
N-glycosylation Affects Stability of OATP1B1
PLOS ONE | www.plosone.org 7 December 2012 | Volume 7 | Issue 12 | e52563
export pump (ABCB11) in MDCK II cells. Am J Physiol Gastrointest Liver
Physiol 292: G818-G828.
19. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D et al. (2000)
Molecular Cell Biology, 4th Ed., W. H. Freeman, New York.
20. Russell D, Oldham NJ, Benjamin GD (2009) Site-selective chemical protein
glycosylation protects from autolysis and proteolytic degradation. Carbohydr
Res 344: 1508–1514.
21. Vashist S, Ng DTW (2004) Misfolded proteins are sorted by a sequential
checkpoint mechanism of ER quality control. J Cell Biol 165: 41–52.
N-glycosylation Affects Stability of OATP1B1
PLOS ONE | www.plosone.org 8 December 2012 | Volume 7 | Issue 12 | e52563
